Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma
2011
We performed complex analysis of the p53 tumor suppressor in
collection of 75 DLBCL cases. Fifty four patients were de novo
cases, twenty one cases developed into DLBCL by transformation
from less aggressive disease. We determined functional status
by analysis of separated alleles in yeast (FASAY) and analyzed
the p53 mutations by cDNA sequencing. We assessed the level of
the p53 protein by immunoblotting analysis. We used FISH to
analyze loss of the p53 and ATM (ataxia telangiectasia mutated)
genes deletion. We detected 16 p53 mutations (21.3%) including
the mutation activating nonsense-mediated RNA decay pathway.
Deletion of the p53 allele was more common in cases with p53
mutation. Mutations and/or deletions of p53 had statistically
significant negative impact on progression-free survival and
tended to decrease also overall survival in 46 de novo DLBCL
patients treated with R-CHOP. p53 aberrations are negative
predictors for survival of DLBCL patients treated with R-CHOP.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
32
Citations
NaN
KQI